Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience

Objective: Interferon-free therapy for hepatitis C virus (HCV) infection is costly, and therefore patients with advanced fibrosis are prioritized. Although coupled with considerable side effects, a large proportion of genotype 2/3 infected patients achieve a sustained virological response (SVR) foll...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Scand J Gastroenterol
Main Authors: Waldenström, Jesper, Färkkilä, Martti, Rembeck, Karolina, Norkrans, Gunnar, Langeland, Nina, Mørch, Kristine, Pedersen, Court, Rauning Buhl, Mads, Nieminen, Urpo, Nuutinen, Hannu, Alsiö, Åsa, Holmström, Lars, Jungnelius, Rolf, Lund, Katarina, Rubensson, Anders, Torell, Erik, Westin, Johan, Lagging, Martin
Formato: Artigo
Idioma:Inglês
Publicado em: Informa Healthcare 2016
Assuntos:
Liver and Biliary Tract
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4732462/
https://ncbi.nlm.nih.gov/pubmed/26418670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/00365521.2015.1087588
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados